GO:1905592 negative regulation of optical nerve axon regeneration: Signaling Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905592 describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of optical nerve axon regeneration.
• The PTEN/mTOR pathway is a central intrinsic brake on optic nerve axon regeneration; PTEN deletion robustly promotes regeneration in adult CNS neurons.
• Co-deletion of PTEN and SOCS3 yields sustained, long-distance axon regeneration beyond what PTEN deletion alone achieves.
• Extrinsic inhibitory cues such as Sema3A act through ROCK2 to suppress retinal ganglion cell axon regeneration.
• Additional regulators include miR-21, Caspr1, and posttranslational modification of Sox11, all of which modulate the regenerative capacity of retinal ganglion cells.
• Understanding negative regulation of optical nerve axon regeneration is critical for developing therapies for optic neuropathies, glaucoma, and traumatic optic nerve injury.
Description
GO:1905592, negative regulation of optical nerve axon regeneration, is a biological process term that captures any mechanism which stops, prevents, or reduces the frequency, rate, or extent of axon regeneration in the optical nerve. This process is of intense interest because the adult mammalian central nervous system (CNS), including the optic nerve, has a very limited capacity for regeneration after injury. Retinal ganglion cells (RGCs), whose axons form the optic nerve, fail to regrow after crush or transection due to a combination of intrinsic and extrinsic inhibitory factors. The PTEN/mTOR pathway is a well-established intrinsic brake: deletion of PTEN in adult RGCs promotes robust axon regeneration. Beyond PTEN, multiple layers of negative regulation exist, including SOCS3-mediated cytokine signaling, Sema3A-ROCK2 signaling, microRNA-21 (miR-21) activity, Caspr1-mediated inhibition via neurofascin, and posttranslational modifications of transcription factors such as Sox11. Understanding these negative regulators is essential for designing combinatorial therapies that unlock the regenerative potential of the injured optic nerve. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:1905592, its molecular players, and experimental approaches for studying it.
negative regulation of optical nerve axon regeneration At A Glance
| GO ID | GO:1905592 |
|---|---|
| GO term | negative regulation of optical nerve axon regeneration |
| Ontology | biological_process |
| Synonym | down regulation of optical nerve axon regeneration; down-regulation of optical nerve axon regeneration; downregulation of optical nerve axon regeneration; inhibition of optical nerve axon regeneration |
| Major function | Suppression of axon regrowth in the optical nerve after injury or in disease states |
| Key pathways | PTEN/mTOR, SOCS3/cytokine signaling, Sema3A/ROCK2, miR-21, Caspr1/neurofascin, Sox11 posttranslational modification |
| Related cell types | Retinal ganglion cells (RGCs), astrocytes, oligodendrocytes |
| Disease relevance | Optic neuropathies, glaucoma, traumatic optic nerve injury, CNS regeneration failure |
What Is GO:1905592?
In our own words, GO:1905592 refers to any biological process that negatively regulates the regeneration of axons in the optical nerve. This includes molecular brakes that suppress the intrinsic growth capacity of retinal ganglion cells, extrinsic inhibitory signals from the environment, and signaling cascades that actively prevent or reduce axon extension after injury.
Why Is negative regulation of optical nerve axon regeneration Important in Cell Biology?
GO:1905592 is critically important because the failure of optic nerve axon regeneration underlies irreversible vision loss in conditions such as glaucoma, optic neuritis, and traumatic optic neuropathy. Identifying the negative regulators of this process provides therapeutic targets to promote RGC survival and axon regrowth, potentially restoring vision. Moreover, the principles learned from optic nerve regeneration often generalize to other CNS injuries, including spinal cord injury.
• Optic nerve regeneration failure is a major cause of irreversible blindness.
• PTEN/mTOR is a master intrinsic brake; its deletion promotes robust regeneration.
• SOCS3 co-deletion with PTEN enables sustained, long-distance regeneration.
• Extrinsic inhibitors like Sema3A signal through ROCK2 to block regeneration.
• miR-21 inhibition reduces astrocyte activation and promotes axon regeneration.
• Caspr1 silencing promotes regeneration in both PNS and CNS via neurofascin.
• Sox11 posttranslational modifications regulate RGC survival and regeneration.
• Understanding these brakes informs combinatorial therapies for CNS repair.
• Models of optic nerve crush are standard for studying regeneration.
• Findings have implications for glaucoma and other optic neuropathies.
What Happens During negative regulation of optical nerve axon regeneration?
Intrinsic Brakes: PTEN/mTOR Signaling
In simple terms: PTEN acts as a brake on the cell's growth machinery, and removing it allows axons to grow.
The PTEN/mTOR pathway is a central intrinsic negative regulator of optic nerve axon regeneration. PTEN deletion in adult retinal ganglion cells activates mTOR and promotes robust axon regeneration after optic nerve crush. This effect is cell-autonomous and requires coordinated permissive signals. The PTEN/mTOR axis thus represents a key node for therapeutic intervention.
Cytokine Signaling: SOCS3
In simple terms: SOCS3 is a protein that dampens growth signals; removing it together with PTEN leads to even more regeneration.
SOCS3 negatively regulates cytokine signaling and suppresses axon regeneration. Co-deletion of PTEN and SOCS3 in adult RGCs induces sustained axon regeneration that far exceeds PTEN deletion alone, demonstrating that multiple intrinsic brakes must be released to achieve long-distance regrowth.
Extrinsic Inhibitory Cues: Sema3A and ROCK2
In simple terms: Sema3A is a repulsive cue that tells growing axons to stop, acting through ROCK2.
Sema3A is a secreted guidance cue that inhibits axonal regeneration of retinal ganglion cells via activation of ROCK2. Blocking this pathway can partially relieve inhibition, highlighting the role of extrinsic factors in negative regulation of optic nerve regeneration.
MicroRNA Regulation: miR-21
In simple terms: miR-21 is a small RNA that promotes scarring and blocks regeneration; inhibiting it helps axons grow.
Inhibition of miR-21 ameliorates excessive astrocyte activation and promotes axon regeneration following optic nerve crush. This indicates that miR-21 acts as a negative regulator of regeneration, at least partly through modulation of the glial scar.
Cell Adhesion and Transcription Factor Control: Caspr1 and Sox11
In simple terms: Caspr1 and Sox11 are proteins that can put the brakes on axon growth; modifying them can enhance regeneration.
Caspr1 silencing promotes axon regeneration in both peripheral and central nervous systems via negative regulation of neurofascin. Additionally, posttranslational modification of Sox11 regulates RGC survival and axon regeneration, adding another layer of negative control.
Key Genes Involved in GO:1905592 negative regulation of optical nerve axon regeneration
The following genes and proteins are key players in the negative regulation of optical nerve axon regeneration, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTEN | Intrinsic brake on mTOR; deletion promotes regeneration | Central target for promoting optic nerve regeneration |
| SOCS3 | Negative regulator of cytokine signaling; co-deletion with PTEN enhances regeneration | Combinatorial target for sustained regeneration |
| Sema3A | Extrinsic inhibitory cue acting through ROCK2 | Blocking Sema3A/ROCK2 relieves inhibition |
| ROCK2 | Kinase mediating Sema3A-induced inhibition | Pharmacological target for disinhibition |
| miR-21 | MicroRNA promoting astrocyte activation and inhibiting regeneration | Inhibition promotes regeneration |
| Caspr1 | Cell adhesion molecule negatively regulating neurofascin | Silencing promotes PNS and CNS regeneration |
| Neurofascin | Target of Caspr1; involved in axon-glia interactions | Modulated by Caspr1 silencing |
| Sox11 | Transcription factor regulated by posttranslational modification | Regulates RGC survival and regeneration |
| mTOR | Central kinase promoting growth; inhibited by PTEN | Effector of PTEN deletion |
| RGCs (retinal ganglion cells) | Neurons whose axons form the optic nerve | Primary cell type for regeneration studies |
| Astrocytes | Glial cells that can form inhibitory scar | Modulated by miR-21 |
| Oligodendrocytes | Myelin-forming cells with inhibitory cues | Contribute to extrinsic inhibition |
| PTEN/SOCS3 double knockout | Genetic model for robust regeneration | Used to study sustained regeneration |
| Sox11 posttranslational modifications | Regulate Sox11 activity | Affect RGC survival and axon growth |
| Caspr1/neurofascin axis | Adhesion complex modulating regeneration | Target for silencing strategies |
| miR-21/astrocyte axis | Inflammatory scarring pathway | Target for anti-scarring therapies |
| Sema3A/ROCK2 axis | Extrinsic inhibitory signaling | Target for disinhibition |
| PTEN/mTOR axis | Intrinsic growth control | Core pathway for regeneration |
How Is negative regulation of optical nerve axon regeneration Regulated?
The negative regulation of optical nerve axon regeneration is controlled by a complex interplay of intrinsic and extrinsic factors. Intrinsically, the PTEN/mTOR pathway acts as a major brake, and its deletion activates mTOR to promote regeneration. SOCS3 provides an additional intrinsic brake, and co-deletion with PTEN leads to synergistic, sustained regeneration. Extrinsically, Sema3A signals through ROCK2 to inhibit regeneration. MicroRNAs such as miR-21 modulate the glial scar and inhibit regeneration. Cell adhesion molecules like Caspr1 negatively regulate neurofascin to suppress regeneration. Posttranslational modifications of transcription factors such as Sox11 also regulate RGC survival and axon growth. These layers of regulation offer multiple targets for therapeutic intervention.
negative regulation of optical nerve axon regeneration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTEN | Optic neuropathy, glaucoma | Optic nerve crush in PTEN conditional KO mice |
| SOCS3 | CNS regeneration failure | PTEN/SOCS3 double KO mice |
| Sema3A | Optic nerve injury | Sema3A inhibition in RGC cultures or in vivo |
| miR-21 | Glial scar, optic nerve crush | miR-21 antagomir treatment in optic nerve crush |
| Caspr1 | PNS and CNS regeneration | Caspr1 silencing in sciatic nerve and optic nerve models |
Optic Neuropathies and Glaucoma
Negative regulation of optical nerve axon regeneration contributes to irreversible vision loss in optic neuropathies and glaucoma. The failure of RGC axons to regenerate after injury is driven by intrinsic brakes such as PTEN and SOCS3, as well as extrinsic inhibitors like Sema3A. Targeting these pathways could promote axon regrowth and preserve vision.
Traumatic Optic Nerve Injury
After traumatic injury to the optic nerve, the regenerative capacity of RGCs is limited by multiple negative regulators. Preclinical studies show that deleting PTEN or co-deleting PTEN and SOCS3 promotes robust axon regeneration. Modulating miR-21 or Caspr1 also enhances regeneration in injury models.
CNS Regeneration Failure
The principles of negative regulation of optic nerve axon regeneration extend to other CNS injuries, such as spinal cord injury. PTEN deletion promotes regeneration in the corticospinal tract and other CNS pathways. Combinatorial targeting of multiple brakes may be necessary for functional recovery.
From negative regulation of optical nerve axon regeneration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PTEN deletion promote optic nerve regeneration? | PTEN conditional knockout in RGCs |
| Does co-deletion of PTEN and SOCS3 enhance regeneration? | PTEN/SOCS3 double knockout mice |
| Does Sema3A inhibit regeneration via ROCK2? | Sema3A treatment and ROCK2 inhibition in RGCs |
| Does miR-21 inhibition promote regeneration? | miR-21 antagomir in optic nerve crush |
| Does Caspr1 silencing promote regeneration? | Caspr1 knockdown in PNS and CNS neurons |
| How do Sox11 modifications affect regeneration? | Sox11 mutant or posttranslational modification mimics |
How to Study the negative regulation of optical nerve axon regeneration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Optic nerve crush | Axon regeneration distance and density | In vivo assessment of regeneration |
| Conditional gene knockout | Effect of gene deletion on regeneration | PTEN, SOCS3 studies |
| Pharmacological inhibition | Effect of drugs on regeneration | ROCK2 inhibitors, miR-21 antagomirs |
| Immunohistochemistry | Protein expression and localization | Caspr1, neurofascin, Sox11 |
| Confocal microscopy | Axon tracing and quantification | Regeneration assays |
| RGC survival counting | Number of surviving RGCs | Neuroprotection studies |
| Western blot | Protein levels and phosphorylation | mTOR pathway activation |
| qRT-PCR | Gene expression changes | miR-21, Sema3A levels |
Optic Nerve Crush and Regeneration Assays
The optic nerve crush model is the gold standard for studying negative regulation of optical nerve axon regeneration. After crush, axons are labeled and regeneration is quantified by counting regenerating axons at various distances from the crush site. This method allows assessment of genetic or pharmacological interventions.
Genetic Manipulation in Mice
Conditional knockout of PTEN, SOCS3, or other genes in retinal ganglion cells using Cre-lox technology enables precise dissection of intrinsic brakes. These models have demonstrated robust regeneration and are essential for mechanistic studies.
Pharmacological and Molecular Interventions
Inhibitors of ROCK2, miR-21 antagomirs, or Caspr1 silencing reagents can be applied to modulate negative regulators. These approaches test the therapeutic potential of targeting specific pathways.
Imaging and Quantification
Confocal imaging of fluorescently labeled axons allows precise quantification of regeneration. Automated image analysis tools improve reproducibility. Survival of RGCs is often assessed by counting labeled cell bodies.
How CRISPR Can Be Used to Study GO:1905592 negative regulation of optical nerve axon regeneration
Knockout
CRISPR knockout of negative regulators such as PTEN or SOCS3 in retinal ganglion cells can mimic genetic deletion studies and promote axon regeneration. This approach enables rapid validation of targets in vitro and in vivo.
Point Mutation
Introducing point mutations in genes like PTEN or Sox11 can dissect specific phosphorylation or interaction sites that mediate negative regulation. This helps identify critical residues for therapeutic targeting.
Knock-in
Knock-in of reporter tags or conditional alleles allows precise tracking of protein localization and function. For example, tagging Sox11 can reveal its posttranslational modifications.
Overexpression
Overexpression of negative regulators such as Sema3A or miR-21 can exacerbate inhibition and confirm their role in blocking regeneration. Conversely, overexpressing dominant-negative constructs can relieve inhibition.
How EDITGENE Supports negative regulation of optical nerve axon regeneration Research
Researchers studying negative regulation of optical nerve axon regeneration-related genes often need to determine whether a candidate gene is causally involved in suppressing axon growth. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of optical nerve axon regeneration research.
Frequently Asked Questions About negative regulation of optical nerve axon regeneration
What is GO:1905592?
GO:1905592 is a Gene Ontology biological process term for any process that stops, prevents, or reduces the frequency, rate, or extent of optical nerve axon regeneration.
What genes are involved in negative regulation of optical nerve axon regeneration?
Key genes include PTEN, SOCS3, Sema3A, ROCK2, miR-21, Caspr1, neurofascin, and Sox11.
How does PTEN inhibit optic nerve regeneration?
PTEN acts as an intrinsic brake on the mTOR pathway; its deletion activates mTOR and promotes robust axon regeneration.
What is the role of SOCS3 in optic nerve regeneration?
SOCS3 negatively regulates cytokine signaling; co-deletion with PTEN leads to sustained, long-distance axon regeneration.
How does Sema3A inhibit retinal ganglion cell axon regeneration?
Sema3A signals through ROCK2 to inhibit axonal regeneration of retinal ganglion cells.
Can miR-21 inhibition promote optic nerve regeneration?
Yes, inhibition of miR-21 ameliorates excessive astrocyte activation and promotes axon regeneration after optic nerve crush.
What is the role of Caspr1 in axon regeneration?
Caspr1 silencing promotes axon regeneration in both peripheral and central nervous systems via negative regulation of neurofascin.
How do Sox11 modifications affect RGC regeneration?
Posttranslational modification of Sox11 regulates RGC survival and axon regeneration.
What experimental models are used to study negative regulation of optic nerve regeneration?
Common models include optic nerve crush in mice, conditional knockout of PTEN or SOCS3, and pharmacological interventions.
Why is optic nerve regeneration important for disease?
Failure of optic nerve regeneration causes irreversible vision loss in glaucoma and optic neuropathies; understanding negative regulators offers therapeutic targets.
Conclusion
GO:1905592, negative regulation of optical nerve axon regeneration, encompasses a complex network of intrinsic and extrinsic brakes that prevent retinal ganglion cell axons from regrowing after injury. Key players include the PTEN/mTOR pathway, SOCS3, Sema3A/ROCK2, miR-21, Caspr1, and Sox11. Targeting these negative regulators, alone or in combination, holds promise for promoting optic nerve repair and treating vision-threatening diseases. Continued research using advanced CRISPR models and screening approaches will accelerate the translation of these findings into therapies.
References
- 1. Park KK et al.. 2008. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway.. Science 322(5903):963-6 PMID: 18988856
- 2. Sun F et al.. 2011. Sustained axon regeneration induced by co-deletion of PTEN and SOCS3.. Nature 480(7377):372-5 PMID: 22056987
- 3. Ma YX et al.. 2026. Caspr1 silencing promotes axon regeneration in both peripheral and central nervous systems via negative regulation of neurofascin.. Biochem Biophys Res Commun 799:153198 PMID: 41519054
- 4. Li HJ et al.. 2018. Inhibition of miR-21 ameliorates excessive astrocyte activation and promotes axon regeneration following optic nerve crush.. Neuropharmacology 137:33-49 PMID: 29709341
- 5. Zhang J et al.. 2018. Coordination of Necessary and Permissive Signals by PTEN Inhibition for CNS Axon Regeneration.. Front Neurosci 12:558 PMID: 30158848
- 6. Chang KC et al.. 2021. Posttranslational Modification of Sox11 Regulates RGC Survival and Axon Regeneration.. eNeuro 8(1) PMID: 33441400
- 7. Zhang J et al.. 2020. Sema3A inhibits axonal regeneration of retinal ganglion cells via ROCK2.. Brain Res 1727:146555 PMID: 31733191
- 8. Huang H et al.. 2019. Lab review: Molecular dissection of the signal transduction pathways associated with PTEN deletion-induced optic nerve regeneration.. Restor Neurol Neurosci 37(6):545-552 PMID: 31839616
